HEATHER AMARAL: Open Payments
NPI 1811473028 · SALISBURY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$664 in 18 payments from 8 companies in 2025. Trend: 2023 $771 · 2024 $1,286 · 2025 $664
Food & beverage: $664
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $269 |
| AstraZeneca Pharmaceuticals LP | 2 | $166 |
| Gilead Sciences, Inc. | 1 | $109 |
| Novo Nordisk Inc | 2 | $36 |
| Dexcom, Inc. | 1 | $30 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| PFIZER INC. | 1 | $18 |
| Amgen Inc. | 1 | $17 |
Products named: AIRSUPRA, QULIPTA, UBRELVY, Epclusa, Wegovy, Dexcom G6 Transmitter, SHINGRIX, PREVNAR 20.
Industry payments across NC — which companies pay providers there.
